SCHEMBL9256954

SCHEMBL9256954

COC(=O)CCc1nnc(-c2ccc(-c3ccc(C#N)cc3)cc2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
GLS O94925 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
BLM P54132 1/20 0.42
MAPT P10636 3/20 0.41
POLB P06746 2/20 0.41
MMP2 P08253 3/20 0.40
MMP3 P08254 3/20 0.40
MMP1 P03956 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
S1PR1 P21453 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9251061 0.88 CYP11B1 (0.52) CYP11B1CYP11B2EGLN1BLMMAPT
SCHEMBL8879099 0.86 HTT (0.48) CYP11B1CYP11B2GLSEGLN1BLM
SCHEMBL3628694 0.80 CYP11B1 (0.56) CYP11B1CYP11B2EGLN1MAPTPOLB
SCHEMBL9254531 0.80 TMPRSS15 (0.43) MAPTHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL3628690 0.79 CYP11B1 (0.55) CYP11B1CYP11B2EGLN1MAPTPOLB
SCHEMBL9257116 0.78 CSNK2A2 (0.42) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL1338556 0.75 CYP11B1 (0.60) CYP11B1CYP11B2MAPTPOLBALDH1A1
SCHEMBL9251931 0.75 CYP11B1 (0.52) CYP11B1CYP11B2EGLN1MAPTPOLB
SCHEMBL161099 0.75 GLS (0.46) GLSBLMMAPTKDM4EHDAC1
SCHEMBL8879927 0.75 SLC22A12 (0.46) GLSEGLN1BLMMMP2MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed